Show simple item record

dc.contributor.authorUpham, John W
dc.contributor.authorLe Lievre, Chantal E.
dc.contributor.authorJackson, David J
dc.contributor.authorMasoli, Matthew
dc.contributor.authorWechsler, Michael E
dc.contributor.authorPrice, David B
dc.contributor.authorDelphi Panel
dc.date.accessioned2022-07-12T23:08:48Z
dc.date.available2022-07-12T23:08:48Z
dc.date.issued2021-07-13
dc.identifier.citationUpham , J W , Le Lievre , C E , Jackson , D J , Masoli , M , Wechsler , M E , Price , D B & Delphi Panel 2021 , ' Defining a severe asthma super-responder : findings from a Delphi process ' , The Journal of Allergy and Clinical Immunology: In Practice . https://doi.org/10.1016/j.jaip.2021.06.041en
dc.identifier.issn2213-2198
dc.identifier.otherPURE: 196210606
dc.identifier.otherPURE UUID: 3c7281fd-5bff-4090-8f20-c5ad2d8367e5
dc.identifier.otherScopus: 85111291256
dc.identifier.urihttps://hdl.handle.net/2164/18845
dc.descriptionFunding Information: This project was supported by in kind contributions from the Observational and Pragmatic Research Institute and the University of Queensland Faculty of Medicine. No pharmaceutical companies were involved in the study design or execution.Conflicts of interest: J.W. Upham reports personal fees from AstraZeneca, GlaxoSmithKline, Sanofi, Boehringer Ingelheim, and Novartis, outside the submitted work. D.J. Jackson reports personal fees from AstraZeneca, GlaxoSmithKline, Boehringer Ingelheim, Teva, Napp, Chiesi, and Novartis; and grants from AstraZeneca, outside the submitted work. M. Masoli reports personal fees from Novartis and AstraZeneca, outside the submitted work. M.E. Wechsler reports grants and personal fees from Novartis, Sanofi, and Cohero Health; personal fees from Regeneron, Genentech, Sentien, Restorbio, Equillium, and Genzyme; grants, personal fees, and nonfinancial support from Teva and AstraZeneca; personal fees and nonfinancial support from Boehringer Ingelheim; and personal fees from GSK, outside the submitted work. D.B. Price reports grants from AKL Research and Development Ltd, British Lung Foundation, Respiratory Effectiveness Group, and UK National Health Service; grants and personal fees from AstraZeneca, Boehringer Ingelheim, Chiesi, Mylan, Novartis, Regeneron Pharmaceuticals, Sanofi Genzyme, Theravance, Zentiva (Sanofi Generics); personal fees from Cipla, GlaxoSmithKline, Kyorin, Merck, Mundipharma, Airway Vista Secretariat, EPG Communication Holdings Ltd, FIECON Ltd, Fieldwork International, OM Pharma SA, PeerVoice, Phadia AB, Spirosure Inc, Strategic North Limited, Synapse Research Management Partners S.L, Talos Health Solutions, and WebMD Global LLC, outside the submitted work; nonfinancial support from Efficacy and Mechanism Evaluation programme and Health Technology Assessment; and stock/stock options from AKL Research and Development Ltd, which produces phytopharmaceuticals; owns 74% of the social enterprise Optimum Patient Care Ltd (Australia and UK) and 92.61% of Observational and Pragmatic Research Institute Pte Ltd (Singapore); and 5% shareholding in Timestamp, which develops adherence monitoring technology. The rest of the authors declare that they have no relevant conflicts of interest. Publisher Copyright: © 2021 American Academy of Allergy, Asthma & Immunologyen
dc.language.isoeng
dc.relation.ispartofThe Journal of Allergy and Clinical Immunology: In Practiceen
dc.rights© 2021. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/en
dc.subjectR Medicineen
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleDefining a severe asthma super-responder : findings from a Delphi processen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPostprinten
dc.identifier.doihttps://doi.org/10.1016/j.jaip.2021.06.041
dc.date.embargoedUntil2022-07-13


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record